The granting of a patent is a significant event for a company as it provides exclusive rights to a product or process, potentially opening up new markets and revenue streams. In this case, DSS Inc's Global BioLife has been granted an Australian patent for a treatment for inflammatory diseases, which could potentially increase the company's revenues and positively impact its stock price in the short term.